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Abstract
Background: a5 nicotinic acetylcholine receptor (nAChR) subunits structurally stabilize functional nAChRs in many
non-neuronal tissue types. The expression of a5 nAChR subunits and cell-specific markers were assessed during
lung morphogenesis by co-localizing immunohistochemistry from embryonic day (E) 13.5 to post natal day (PN) 20.
Transcriptional control of a5 nAChR expression by FoxA2 and GATA-6 was determined by reporter gene assays.
Results: Steady expression of a5 nAChR subunits was observed in distal lung epithelial cells during development
while proximal lung expression significantly alternates between abundant prenatal expression, absence at PN4 and
PN10, and a return to intense expression at PN20. a5 expression was most abundant on luminal edges of alveolar
type (AT) I and ATII cells, non-ciliated Clara cells, and ciliated cells in the proximal lung at various periods of lung
formation. Expression of a5 nAChR subunits correlated with cell differentiation and reporter gene assays suggest
expression of a5 is regulated in part by FoxA2, with possible cooperation by GATA-6.
Conclusions: Our data reveal a highly regulated temporal-spatial pattern of a5 nAChR subunit expression during
important periods of lung morphogenesis. Due to specific regulation by FoxA2 and distinct identification of a5 in
alveolar epithelium and Clara cells, future studies may identify possible mechanisms of cell differentiation and lung
homeostasis mediated at least in part by a5-containing nAChRs.
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Background
Pulmonary development adheres to orchestrated processes
that require precisely regulated reciprocal interactions
between developing respiratory epithelium and the sur-
rounding splanchnic mesenchyme. Proper lung develop-
ment involves both spatial and temporal control of a
myriad of factors including transcription factors, growth
factors, cell surface receptors, and extracellular matrix
constituents. Notably, lung development requires cell
migration during branching morphogenesis, cell polariza-
tion, and differentiation of specialized cells along the prox-
imal/distal pulmonary axis [1]. Diverse transcription
factors and signaling proteins function in intricate signal-
ing and regulatory mechanisms during pulmonary cell dif-
ferentiation. Such important contributing molecules
include FoxA2, and GATA-6 [2,3]. FoxA2 is a transcrip-
tion factor prominently expressed by the lung that con-
tains a winged helix DNA binding domain [4]. Necessary
for the formation of foregut derivatives, FoxA2 functions
in the differentiation of respiratory epithelium and contri-
butes to normal branching morphogenesis and cell com-
mitment [2]. Later in development, FoxA2 regulates
several genes required for lung function after birth includ-
ing surfactant proteins, TTF-1, Muc5A/C, E-cadherin and
Vegfa [5-9]. GATA-6 is a zinc-finger containing transcrip-
tion factor expressed by respiratory epithelial cells
throughout lung morphogenesis. GATA-6 is required for
specialization of bronchiolar epithelium [10] and it contri-
butes to sacculation and alveolarization in concert with
numerous other transcriptional regulators [11,12]. At pre-
cise time points, signaling involving these and other mole-
cules mediate epithelial-mesenchymal interactions and
provide signals that induce lung-specific genetic programs
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the functional contributions of critical genes during devel-
opment depend on precise expression patterns that result
from mechanisms initiated by signal transduction path-
ways. Understanding cell populations that co-express
important regulatory proteins and specific cell surface
receptors may identify relevant receptors that contribute
to transcription factor expression and ultimate lung
formation.
Neuronal nicotinic acetylcholine receptors (nAChRs) are
ligand-gated cation channels that form the principal exci-
tatory neurotransmitter receptors in the peripheral ner-
vous system [13]. Specifically, nAChRs mediate chemical
neurotransmission among neurons, ganglia, interneurons,
and the motor endplate. The biology of nAChRs has
expanded in recent years due to nAChR localization in
several non-neuronal tissues, including the lung [14,15].
NAChRs are pentameric oligomers composed of five sub-
units that surround a central ion channel through which
ions flow following ligand binding. Receptor subunits have
been identified as either agonist binding (a2, a3, a4, a6, a7,
a9 and a10) or structural (a5, b2, b3 and b4) [13,16]. In the
current investigation, the a5 subunit and cell-specific mar-
kers were co-localized in the developing mouse lung by
immunohistochemistry so that pulmonary cell types that
express a5 could be identified. These studies involved
well-characterized antibodies that identify non-ciliated
Clara cells and ciliated epithelial cells in the proximal
lung, alveolar type II (ATII) cells that secrete surfactant
proteins, and alveolar type I (ATI) cells that contribute
abundantly to the respiratory membrane. Because expres-
sion corresponded with differentiating lung epithelial cells
influenced by FoxA2 and GATA-6, experiments were con-
ducted in order to test the hypothesis that these important
pulmonary transcription factors regulate a5. Although lit-
tle data regarding the expression pattern and specific con-
tributions of a5 nAChR subunits previously existed,
identification on specific pulmonary cells is an critical first
step in eventually assessing possible cholinergic signaling
pathways that likely influence normal and abnormal lung
formation [17].
Methods
Animals
C57BL/6 mice were housed and used in accordance with
approved IACUC protocols at Brigham Young University.
Male and female mice were mated and the discovery of a
vaginal plug was identified as embryonic day (E) 0.
Antibodies and Immunohistochemistry
A rabbit a5 polyclonal antibody generated against cyto-
plasmic epitopes was used at a dilution of 1:800 to iden-
tify a5 nAChR subunits in the lung during development.
Immunobotting and ELISAs were used to determine the
specificity of the a5 antibody and it was determined to
be effective with tissues embedded in paraffin [18]. A
rabbit polyclonal antibody against Clara Cell Secretory
Protein (CCSP, Seven Hills Bioreagents, Cincinnati, OH)
was used at a dilution of 1:1600. A monoclonal antibody
for Fox J1 (Seven Hills BioReagents) was used at a dilu-
tion of 1:2000. ATII epithelial cells were specifically
identified by staining with a rabbit anti-N-terminal
proSP-C polyclonal antibody (1:1000, Seven Hills BioR-
eagents) and ATI cells were localized via staining with a
monoclonal hamster anti-mouse antibody raised against
T1a at a dilution of 1:2000 (Clone 8.1.1, Developmental
Studies Hybridoma Bank, Department of Biology, Uni-
versity of Iowa, Iowa City, IA). Immunohistochemical
staining involved six mice per time point and staining
for each antibody was conducted on three different
slides. Immunostaining for CCSP, proSP-C, T1a,F o x J 1
and a5 was performed with 5-μm serial sections begin-
ning at E18.5 because this period coincided with ele-
vated a5 expression and the differentiation status of
epithelial cells that express these markers [19,20]. Stain-
ing of serial sections was selected over preferred meth-
ods of dual labeling immunofluorescence because
specific staining using multiple rabbit polyclonal antibo-
dies in the same slide is not easily reproducible. Sections
were deparaffinized, and rehydrated by incubation in
100%, 95%, and 70% ethanol then treated with 3%
hydrogen peroxide in methanol for 15 min to quench
endogenous peroxidase. Following block in 2.0% normal
goat serum in PBS for 2 hr at room temperature, sec-
tions were incubated with CCSP, proSP-C, T1a,o ra5
primary antibody at 4°C overnight. Control sections
were incubated in blocking serum alone. After overnight
incubation with primary antibody, all sections (including
controls) were washed and positive staining was
detected using biotinylated goat anti-rabbit secondary
antibodies and a Vector Elite ABC kit (Vector Labora-
tories; Burlingame, CA). Development in nickel diami-
nobenzidine was followed by incubation in Tris-cobalt
(which enhances antigen localization), and counterstain-
ing was conducted with nuclear fast red. Sections were
dehydrated by incubation in 70%, 95%, and 100% etha-
nol, washed in three changes of HistoClear (Fisher
Scientific, Waltham, MA), and mounted under cover
slips with mounting medium. Immunohistochemical
staining for FoxJ1 was completed using a “Mouse on
Mouse” monoclonal antibody kit (Vector) in accordance
with the manufacturer’s instructions. Individuals blinded
to the antibody used initially imaged the serial sections
and co-localization was determined by comparing
immunolabeling of a5 with cells that express CCSP,
FoxJ1, proSP-C, or T1a.
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0.85-kb of the mouse a5 promoter was obtained by
polymerase chain reaction (PCR), ligated into a pGL4.10
reporter vector (Promega, Madison, WS) and verified by
sequencing as described previously [21]. Site-directed
mutagenesis of a potential FoxA2 binding site (-488)
was performed by using the 0.85-kb reporter construct
and the QuickChange™ Site-Directed Mutagenesis kit
(Stratagene, La Jolla, CA). The sequence verified mutant
reporter contained synthetic oligonucleotides for the
desired mutation for FoxA2 (CATTTA®GGGGGG).
Functional assays of reporter gene constructs were per-
formed by transient transfection of Beas-2B and A549
cells using FuGENE-6 reagent (Roche, Indianapolis, IN)
[21]. Beas-2B is a transformed human bronchiolar
epithelial cell line and A549 is a human pulmonary ade-
nocarcinoma cell line characteristic of ATII cells [22].
Transfections included 500 ng pRSV-bgal, 100 ng
pGL4.10-0.85-kb a5, 100-400 ng pCMV-FoxA2 or
pCMV-GATA-6 and pcDNA control vector to bring
total DNA concentration to 1.4 μg. After 48 hours,
plates were scraped and centrifuged, and the cleared
supernatant was used for both b-gal and luciferase
assays such that assays were normalized for transfection
efficiency based on the b-gal activity [19]. Data pre-
sented are representative of three different experiments,
all performed in triplicate.
Statistical Analysis
Results are presented as the means ± S.D. of six replicate
pools per group. Means were assessed by one and two-
way analysis of variance (ANOVA). When ANOVA indi-
cated significant differences, student t tests were used
with Bonferroni correction for multiple comparisons.
Results are representative and those with p values < 0.05
were considered significant.
Results
Temporal/spatial pattern of a5 expression in developing
mouse lung
The distribution of a5 expression in mouse lung was
assessed by immunohistochemistry from E13.5 to PN20.
At E13.5 (Figure 1A) and E15.5 (Figure 1B), a5 was primar-
ily detected in epithelial cells that comprise the primitive
conducting airways of the developing lung and only spora-
dically expressed in mesenchyme. At E18.5 (Figure 1C),
and PN1 (Figure 1D), a5 was predominantly expressed in
proximal lung epithelial cells with diminished expression in
distal lung epithelium. At PN4 (Figure 1E), a5 was detected
in the distal lung, while staining in the conducting airways
was markedly decreased. This shift in a5 expression from
proximal to distal lung epithelium at PN1 and PN4 was
also observed at PN10 (Figure 1F). At PN20 (Figure 1G),
robust a5 expression returned to proximal lung epithelium
while a5 localization persisted in the distal lung. No stain-
ing was observed in sections stained without primary anti-
body (Figure 1H).
Association of a5 expression with cell-specific markers
In order to identify specific cell populations that express
a5, co-localizing immunohistochemistry was performed
on serial sections obtained from mice at E18.5 through
PN20. During the early saccular period (E18.5), a5 was co-
expressed with FoxA2, a general marker of primitive
respiratory and airway epithelium in the proximal and dis-
tal lung (Figure 2A, B). Co-expression of a5 and FoxA2
was also detected in proximal and distal pulmonary
epithelium at PN1 (Figure 2C, D), PN4 (Figure 2E, F), and
PN20 (Figure 2G, H). Expression by differentiating ATII
cells at E18.5 was confirmed by co-localizing a5 expression
with proSP-C (Figure 3A,B ) .S t a i n i n gf o rT 1 a,a nA T I -
specific marker, revealed that a5 was not expressed by
ATI cells at E18.5 (Figure 3C, D). Significant co-localiza-
tion with CCSP, a marker for Clara cells in the proximal
lung, was also observed at E18.5 (Figure 3E, F).
At PN1, a period that coincides with the mid-saccular
stage, a5 was detected in only a minority of ATII cells via
proSP-C co-localization (Figure 4A, B) and ATI cells
stained for T1a (Figure 4C, D). At PN1, significant detec-
tion of a5 in CCSP-positive Clara cells (Figure 4E, F) and
cells that express FoxJ1 (Figure 4G, H), a transcription
factor vital in ciliogenesis, revealed a5 expression in both
non-ciliated and ciliated bronchiolar epithelium. At the
end of the saccular period (PN4), staining for proSP-C
(Figure 4I, J) and T1a (Figure 4K, L) revealed that a5 was
expressed by ATII and ATI cells, respectively. Immunos-
taining with CCSP (Figure 4M, N) and FoxJ1 (Figure 4O,
P) reveal that a5 expression is absent in non-ciliated
Clara cells and ciliated epithelial cells in the proximal
lung. These data suggest that a5 expression is chiefly
identified on Clara cells in the proximal lung at PN1 and
on ATII and ATI cells in the distal lung at PN4.
During the mid-alveolar stage of lung development
(PN10), staining performed with proSP-C revealed that
most but not all ATII cells express a5 (Figure 5A, B)
and staining for T1a demonstrated that ATI cells
express a5 (Figure 5C, D). As was observed at PN4,
CCSP co-immunostaining revealed no detectable a5
expression in proximal lung epithelium (Figure 5E, F). A
significant general observation near the end of the
alveolar period (PN20) was that a5 staining markedly
returns to the large airways at the conclusion of alveolo-
genesis. Co-localization with proSP-C-positive ATII cells
(Figure 5G, H) and T1a-positive ATI cells (Figure 5I, J)
confirmed a5 expression by alveolar epithelial cells.
Staining for CCSP also revealed markedly increased a5
expression by proximal bronchiolar epithelium (Figure
5K, L).
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Page 3 of 11Figure 1 Immunolocalization of a5 nAChR subunits during periods of murine lung morphogenesis. a5 was primarily detected in primitive
respiratory epithelium at E13.5 (A, arrow) and E15.5 (B, arrow) and only minimally detected in mesenchyme (arrowheads). During the saccular
stage of lung development (E18.5, C and PN1, D), a5 was prominently located on respiratory epithelium in the larger airways (arrows). Expression
of a5 in airway epithelium was diminished at PN4 (E, arrow) and PN10 (F, arrow) and common in distal lung epithelium (arrowheads). At PN20,
robust expression of a5 was again detected throughout the proximal lung airways (G, arrow) and expression persisted in the periphery (G,
arrowhead) at the completion of alveologenesis. No immunoreactivity was observed in PN20 lung sections incubated without primary antibody
(H). All images are at 40X original magnification and scale bars represent 50 μm.
Porter et al. Respiratory Research 2011, 12:82
http://respiratory-research.com/content/12/1/82
Page 4 of 11Transcriptional Control of a5 in pulmonary epithelium by
FoxA2 and GATA-6
Because the expression pattern of a5 nAChR subunits
coincided with differentiating pulmonary epithelial cells
in both the proximal and distal lung compartments, we
sought to determine the regulatory effects of FoxA2 and
GATA-6 on a5 transcription. Reporter gene assays in
bronchiolar Beas-2B cells revealed that a5 transcription
is significantly increased by FoxA2 (Figure 6A). While
increasing concentrations of GATA-6 alone had no
effect on a5 transcription (not shown), when combined,
both FoxA2 and GATA-6 synergistically induced
Figure 2 Co-immunostaining of a5 nAChR subunits and FoxA2 during periods of lung development. a5 (A, C, E, G) was observed in cells
that also express FoxA2 (B, D, F, H). Prominent co-expression was observed in airway epithelium (arrows) at E18.5 (A, B), PN1 (C, D), and PN20 (G,
H). Co-expression of a5 and FoxA2 was also detected in respiratory epithelium (arrowheads) at PN1 (C, D), PN4 (E, F), and PN20 (G, H).
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alveolar type II-like A549 cells, FoxA2 also significantly
increased a5 transcription in a dose dependent manner
(Figure 6A); however, GATA-6 had no measurable
effect, either individually (not shown) or in combination
with FoxA2 (Figure 6A). Mutagenesis of a single puta-
tive FoxA2 response element resulted in complete abla-
tion of FoxA2 transcriptional activation of a5 expression
in both Beas-2B and A549 cells (Figure 6B). Further-
more, possible interactions between FoxA2 and GATA-
6 in the regulation of the a5 gene were also inhibited
when the possible FoxA2 response element was
removed (Figure 6B).
Discussion and Conclusions
Immunostaining for a5 nAChR subunits revealed an inter-
esting pattern of expression during periods of lung forma-
tion. Utilization of antibodies for cell-specific markers
demonstrated that various pulmonary epithelial cell popu-
lations express a5 subunits during distinct periods of lung
organogenesis. An intriguing discovery was that a5 expres-
sion experienced profound shifts between proximal and
distal lung epithelial cells during perinatal milestones. For
example, conducting airway epithelial cell expression per-
sisted throughout embryonic and post-natal lung morpho-
g e n e s i se x c e p ta tP N 4a n dP N 1 0 ,ap e r i o dt h a ti s
characterized by parenchymal differentiation in the alveo-
lar period of lung formation. Furthermore, staining in the
distal lung was evident at E18.5, but noticeably diminished
at PN1. Precise regulation of a5 nAChR subunits that sta-
bilize a subset of functional pentameric nAChRs suggests
the possibility that nAChR-mediated signaling may partici-
pate in specific epithelial cell differentiation trajectories.
Because immunolocalization of a5 was primarily
detected on luminal membranes of various epithelial cell
populations, it is likely that a5 subunits accumulate on
the apical surface in order to contribute to functional
nAChRs. Furthermore, intense expression at PN20, a
period that coincides with the final stages of alveologen-
esis occurring from PN5-30 in the mouse [23], suggests
a5 may function in the maintenance of the post-natal
lung. It is possible that a5-containing nAChRs function
in utero by binding ligand and inducing signal transduc-
tion required during embryonic development. These
possibilities are supported by previous research that
identify functional nAChRs in various lung epithelial
cells [24-26]. Because a5 co-localizes with multiple tran-
scription factors essential in lung development such as
TTF-1 [21], FoxA2, and GATA-6, our data clearly sug-
gest that a5-containing nAChRs may function in med-
iating paracrine communication between respiratory
epithelial cell populations.
Figure 3 Immunostaining of a5 nAChR subunits, proSP-C, T1a, and CCSP during the mid-saccular period of lung development (E18.5).
a5 (A, B) was co-expressed with proSP-C (B, arrows) in most ATII cells. a5 was expressed in non-ATI cells in respiratory airways (C, D arrows) and
poorly expressed by T1a-positive ATI cells (C, D arrowhead). a5 (E) was also expressed by non-ciliated Clara cells in the proximal lung as revealed
by CCSP co-localization (F, arrows). Lung sections stained without primary antibodies were negative (not shown). All images are at 40X original
magnification and scale bars represent 50 μm.
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expressed with TTF-1 [21]. TTF-1 is a molecule
expressed in lung periphery during early pulmonary
development and critical in regulating the expression of
genes necessary for branching morphogenesis and cell
differentiation [5,27,28]. The importance of TTF-1 is
demonstrated by severe hypoplastic lung malformation
observed in mice lacking TTF-1 [29]. The concept that
a5 and TTF-1 cooperate in signaling is supported by
site-directed mutagenesis data from our lab that reveal
TTF-1 transcriptionally regulates a5 expression via
binding to specific TTF-1 response elements located in
the proximal a5 promoter [21]. Co-localization of a5
with cells that express FoxA2 also increases the likeli-
hood that a5 may function in pulmonary cell differentia-
tion. FoxA2 is a protein that contains a winged double
helix DNA binding domain [4] and it is expressed in an
overlapping pattern with TTF-1 [30]. FoxA2 directly
and in combination with GATA-6 influences respiratory
epithelial cell differentiation [2] and it significantly regu-
lates the promoters of a5 (Figure 6) and TTF-1 [6]
in vitro. Therefore, it is possible that TTF-1 and FoxA2
Figure 4 Immunostaining of a5 nAChR subunits, proSP-C, T1a, CCSP, and FoxJ1 during the mid-saccular post natal period (PN1) and
late saccular period (PN4) of lung development. a5 (A, C) did not clearly co-localize with proSP-C expressing ATII cells (B) and was detected
in some ATI cells stained with T1a (D, arrows) but not all (D, arrowhead). a5 expression (E, G) was abundantly detected in the proximal lung as
evidenced by co-expression by CCSP-expressing Clara cells (F, arrow) and ciliated cells in the proximal airways that express FoxJ1 (H, arrow). At
PN4, a5 (I, K) was co-expressed by ATII and ATI cells via co-localization with proSP-C (J, arrow) and T1a (L, arrow), respectively. PN4 was a period
in which a5 expression was nearly absent in the proximal lung, therefore co-localization with CCSP in Clara cells (N, arrowhead) and FoxJ1 in
ciliated cells (P, arrowhead) was poor. Lung sections stained without primary antibodies were negative (not shown). All images are at 40X
original magnification and scale bars represent 50 μm.
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cell differentiation pathways, including a5 nAChR subu-
nits. Specifically relevant to the current study is the dis-
covery that a single putative FoxA2 binding site exists in
the proximal a5 promoter and that plausible GATA-6
binding sites are absent. This suggests that possible
transactivation by GATA-6 is likely mediated by other
DNA-binding proteins such as FoxA2. Importantly,
our research may clarify additional functions of TTF-1
and FoxA2 that already are known to interact in the
Figure 5 Immunostaining of a5 nAChR subunits, proSP-C, T1a, and CCSP during the mid-alveolar (PN10) and near the conclusion of
the alveolar period (PN20) of lung development. a5 (A, C) expression at PN10 persisted in distal lung ATII cells that express proSP-C (B,
arrows) and ATI cells that express T1a (D, arrows). This period also coincided with undetectable a5 expression in the proximal lung (E) revealing
no co-localization with CCSP (F, arrowhead). At PN20, a5 (G, I) expression remained detectable in ATII cells that express proSP-C (H, arrows) and
ATI cells that express T1a (J, arrows). This period agreed with a return to robust a5 expression in the proximal lung (K, arrow), most notably by
Clara cells that express CCSP (L, arrow). Lung sections stained without primary antibodies were negative (not shown). All images are at 40X
original magnification and scale bars represent 50 μm.
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CCSP, surfactant proteins, growth factors, and Vegfa/
Vegfr2 interactions essential in vasculogenesis [30].
Despite clear localization of a5 with TTF-1 [21] and
FoxA2 (Figure 2), as well as cell-specific markers such as
CCSP and proSP-C, co-localization was not completely
identical. For instance, epithelium specific transcription
factors such as TTF-1 and FoxA2 have not been func-
tionally characterized as factors that control mesenchy-
mal gene expression. Therefore, a5 expression is likely
controlled by the activity of many overlapping factors
such as TTF-1, FoxA2, Gata-6, NF-1, RAR, and AP-1,
and the precise pattern of a5 expression is plausibly influ-
enced by complex interplay between competing and
redundant activators [31].
At PN1, a5 co-localized with FoxJ1, a nuclear protein
vital in the regulation of multiple genes necessary for
ciliogenesis in ciliated cells resident in conducting air-
ways [32,33]. The fact that co-localization with FoxJ1 was
not observed after PN1 reveals that differentiated ciliated
bronchiolar epithelial cells may not require a5 subunit
expression at the onset of alveologenesis. Once a5
expression returned to the proximal lung at PN20, co-
localization was most prominent in non-ciliated Clara
cells, suggesting possible roles for a5-containing nAChR
signaling in protective functions and regenerative capa-
city mediated by Clara cells in the conducting airways
[34].
Cell differentiation and proper organ formation involves
complex interrelated mechanisms that can be deleteriously
altered when noxious ligands are present. For instance, the
availability of nicotine during important periods of lung
development can affect normal lung developmental pro-
grams. Our data reveal that a5-containing nAChRs are
expressed on ATI, ATII, Clara and ciliated epithelial cells,
all of which are affected when nicotine crosses the pla-
centa during development. Specifically, exposure to cigar-
ette smoke during pregnancy adversely affects lung
Figure 6 FoxA2 induced a5 transcription in bronchiolar and alveolar epithelial cell lines. FoxA2 dose-dependently induced a5
transcription by acting on a 0.85-kb a5 reporter in Beas-2B and A549 cells (A). FoxA2 and GATA-6 also cooperated to induce a highly significant
increase in a5 transcription in Beas-2B cells (A) but did not elicit a similar increase in A549 cells. Mutagenesis of a single putative FoxA2 response
element completely eliminated FoxA2-mediated increases in a5 transcription and inhibited FoxA2-GATA-6 cooperation in the regulation of a5
gene expression (B). Significant differences in luciferase levels compared to reporter alone are noted at P ≤ 0.05 (*) and P ≤ 0.01 (**).
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genesis [35], increasing rates of respiratory illness [36],
irreversibly altering pulmonary function [37], and perma-
nently obstructing proximal lung airways [38]. Important
research performed by Carlisle et al. involving the charac-
terization of nAChR subunits in the lungs of never smo-
kers, ex-smokers, and active smokers revealed altered
nAChR expression depending on smoke status [39]. At
the protein level, a5 is up-regulated by pulmonary epithe-
lium in response to chronic nicotine exposure and there
were fewer never smokers that express a5 protein com-
pared to active smokers (p < 0.05) [39]. Our studies
demonstrate that a5-containing nAChRs are expressed in
populations of epithelial cells during normal lung develop-
ment; however, a5-containing nAChRs may also function
during morphological perturbation of the lung when nox-
ious ligands such as nicotine are present.
In summary, cellular expression of a5 nAChR subunits
varies during lung morphogenesis. a5 is expressed in distal
lung epithelial cells during development while proximal
lung expression markedly alternates between intense pre-
natal expression, absence at PN4 and PN10, and a return
to pronounced expression at PN20. a5 expression was
observed in differentiating ATI and ATII cells and proxi-
mal Clara and ciliated cells at specific time points of organ
formation, and adult expression is consistently identified
in respiratory epithelium and Clara cells. The data suggest
that expression of a5-containing nAChRs is specifically
controlled during lung morphogenesis and that regulation
occurs in part by FoxA2 and Gata-6. However, the precise
functions of a5 in the maturing lung are still unclear.
Experiments aimed at discovering possible roles for a5,
including gene targeting in cells that persistently express
or block a5 both during and after morphogenesis, are
underway and should provide additional clues into the
biology of a5 subunits.
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